Interleukins (IL), also known as "white cell stimulators," are a type of cytokines first found to be produced by white blood cells and act between them.

TIL therapy uses the patient's own immune cells from the solid tumor microenvironment to kill tumor cells.

Fusion protein technology is a purposeful gene fusion and protein expression method to obtain large amounts of standard fusion proteins.

Recently, AstraZeneca published in JMC, detailing the development of the inhaled JAK1 inhibitor AZD4604.

Antitoxin is a specific antibody or serum containing this antibody that can neutralize toxins. By using toxoids for immunization, the body can produce corresponding antitoxins to prevent diseases.

This article will review currently applied listed GPCR-targeting drugs, and the associated popular GPCR class targets and drug development opportunities worth paying attention to.

Gene Therapy Company focuses on correcting or compensating for diseases caused by abnormal genes by introducing foreign normal genes into target cells.

Biosimilar drugs: These are therapeutic biological products that have similarity in quality, safety, and efficacy with a previously registered reference drug.

miRNA is an endogenous tiny non-coding RNA, generally 21-23 nucleotides long, with the function of regulating gene expression at the translational level.

Pre-exposure prophylaxis (PrEP) is a preventive measure that involves the use of antiretroviral drugs to reduce the risk of HIV infection in individuals who are not infected but are at high risk of exposure.

Currently, CAR-T therapy has promising potential in the field of multiple myeloma treatment.

Cell therapy refers to the transplantation or infusion of normal or bioengineered human cells into a patient’s body.